Immunotherapy With CD19 CAR T-cells for B-Cell Leukemia
Clinical trial NCT04100187 · UNKNOWN
Trial details
- NCT number
- NCT04100187
- Sponsor
- Kecellitics Biotech Company Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2023-08-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.